Mkts

Ovid Therapeutics Inc.

NASDAQ: OVID
$2.54-0.01 (-0.39%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
2.332.56
52-week range
1.183.10
Today
Open2.50
Previous close2.54
Volume—
Valuation
Market cap479.38M
P/E ratio—
EPS (TTM)-0.25
Income & risk
Dividend / yield—
Beta0.31
Avg volume1.78M
Discussion

OVID News

Stories mentioning OVID from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.00718.00132.006,272130.0076.00173.00169.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development11,1816,5885,8706,4656,6595,9337,85512,582
Sales General & Admin
Total Operating Expenses17,84613,01112,65511,34512,68010,80113,39920,686
Operating Income (Loss)(17,846)(12,293)(12,523)(5,073)(12,550)(10,725)(13,226)(20,517)
Interest Income737.00848.00303.00384.00491.00650.00947.00991.00
Interest Expense
Other Expense858.0021,957365.00389.002,3151,471(780.00)29,038
Pretax Income(16,988)9,663(12,158)(4,684)(10,235)(9,254)(14,006)8,521
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(16,988)9,663(12,158)(4,684)(10,235)(9,254)(14,006)8,521
Earnings Per Share (Basic)(0.20)0.12
Earnings Per Share (Diluted)(0.20)0.12
Weighted Average Shares Outstanding (Basic)70,97670,916
Weighted Average Shares Outstanding (Diluted)70,97671,201

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OVID

Ovid Therapeutics Inc. (NASDAQ: OVID) is a stock listed on the Nasdaq Stock Market under the ticker symbol OVID. It last traded at $2.54 (Nov 13, 2026, 4:00 PM ET), down 0.4% on the day. That gives Ovid Therapeutics a market capitalisation of $479.4M.

Over the past 52 weeks OVID has traded between $1.18 and $3.10.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $17.0M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$0-$17.0M—
Dec 31, 2025$718.0K$9.7M1345.8%
Sep 30, 2025$132.0K-$12.2M-9210.6%
Jun 30, 2025$6.3M-$4.7M-74.7%

From Ovid Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…